(a) Insulin Secretion |
|
Speer et al. [78] 2001 |
49 Caucasians with T2DM, 29 subjects with obesity but no T2DM, 138 healthy controls |
BsmI |
Fasting and postprandial C-peptide |
Higher postprandial C-peptide in BB genotype among T2DM and obese subjects |
Highest postprandial C-peptide in subjects with BB and estrogen receptor polymorphism |
Hitman et al. 1998 [79] |
171 Bangladeshi Asians |
TaqI, BsmI, ApaI |
OGTT |
Higher insulin secretion index in AA genotype |
No genotype differences in 32, 33 split proinsulin |
Ogunkolade et al. 2002 [80] |
143 healthy Bangladeshi Asians |
TaqI, BsmI, Fokl, ApaI |
OGTT |
TaqI genotype independently predicted insulin secretion index; tt genotypes had greatest insulin secretion index |
— |
|
(b) Insulin resistance |
|
Filus et al. 2008 [81] |
176 Polish men |
Fokl, BsmI |
Fasting insulin and glucose |
FF/Ff genotype associated with greater fasting insulin than ff |
BB genotype associated with greater BMI and waist circumference; FF genotype associated with lower HDL-C |
Chiu et al. 2001 [82] |
49 glucose-tolerant Caucasian Americans |
FokI |
Fasting insulin and glucose |
ff/Ff genotypes had higher fasting insulin and HOMA-IR than FF; FokI genotype independently predicted HOMA-IR |
ff/Ff genotypes had higher postchallenge insulin AUC; higher WHR in ff/Ff genotypes; HOMA-β did not differ between genotypes |
Oh and Barret-Connor 2002 [83] |
1545 Caucasian Americans |
TaqI, BsmI, ApaI |
Fasting insulin and glucose |
Fasting glucose higher in aa genotype (ApaI); HOMA-IR higher in BB genotype (BsmI) |
Trend towards higher aa frequency in subjects with T2DM versus those without (P = .058) |
Ortlepp et al. 2003 [84] |
1539 healthy, male German soldiers |
BsmI |
Fasting glucose |
Fasting glucose independently associated with BsmI VDR (BB genotype) only in subjects with low physical activity |
— |
Tworowska-Bardińska et al. 2008 [85] |
350 healthy, Polish postmenopausal women |
BsmI |
Fasting insulin and glucose |
No difference in fasting insulin, glucose, or fasting insulin resistance index between genotypes |
Greater LDL-C in BB genotype among those with central obesity |
|
(c) Type 2 Diabetes |
|
Ortlepp et al. 2003 [84] |
293 German adults at risk for coronary artery disease |
BsmI |
— |
Higher T2DM prevalence in BB versus bb genotype; OR of 3.64 (CI: 1.53–8.55) |
Higher coronary artery disease prevalence in BB genotype |
Dilmec et al. 2009 [86] |
72 Turkish adults with T2DM versus 169 healthy controls |
TaqI, ApaI |
— |
No statistical difference in genotype frequencies among cases versus controls |
No difference in fasting plasma glucose or HbA1c among subjects with VDR polymorphisms versus those without |
Malecki et al. 2003 [87] |
308 Polish adults with T2DM versus 240 controls |
TaqI, BsmI, Fokl, ApaI |
— |
No statistical difference in genotype frequencies among cases versus controls |
— |
Ye 2001 et al. [88] |
309 Caucasians (French) with T2DM versus 143 controls |
TaqI, BsmI, Tru9I, ApaI |
— |
No statistical difference in genotype frequencies among cases versus controls |
TT (TaqI) and bb (BsmI) genotypes associated with BMI among subjects with early onset T2DM |
Boullu-Sanchis et al. 1999 [89] |
89 migrant Indians of Guadeloupe with T2DM versus 100 controls |
TaqI, ApaI |
— |
No statistical difference in genotype frequencies among cases versus controls |
— |